Do you find our website to be helpful?
Yes   No

Blog Articles

COMPASS Trial: A Direct Aspiration First Pass Technique

Intravenous (IV) tissue plasminogen activator (tPA) administration has been shown to be safe and effective for treatment of Acute Ischemic Stroke (AIS) within 3 hours of symptom onset, and newer evidence has shown potential benefit out to 4.5 hours.

Apr 21st, 2017
We Are Committed to Clinical Research

RIA has a rich history of participation in clinical research and innovation dating back to the 1980s.  Many of our physicians believe it is important to contribute to science and advance medicine. 

Mar 16th, 2017
ESCAPE: Changing the way stroke patients are treated

Our neurointerventional surgeons were key contributors to this landmark clinical trial that demonstrated the benefits of endovascular treatment compared to conventional treatment for patients with acute ischemic stroke.

Feb 14th, 2017